Oxidative stress in nonobese women with polycystic ovary syndrome: Correlations with endocrine and screening parameters

Gynecologic and Obstetric Investigation

Volumn 65, Issue 4, 2008, Pages 233-239

  Verit, Fatma Ferda ^a   Erel, Ozcan ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Endocrine parameters, polycystic ovary syndrome; Oxidative stress; Polycystic ovary syndrome; Total antioxidant status

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL EXAMINATION; COLORIMETRY; CONTROLLED STUDY; ECHOGRAPHY; ENDOCRINE FUNCTION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCREENING TEST;

ADULT; ANTIOXIDANTS; BODY MASS INDEX; DEHYDROEPIANDROSTERONE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN RESISTANCE; LUTEINIZING HORMONE; MASS SCREENING; ORGAN SIZE; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; SEX HORMONE-BINDING GLOBULIN;

EID: 44849089629     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113046     Document Type: Article

References (63)

1. Franks S: Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
2. Hacihanefioglu B: Polycystic ovary syndrome nomenclature: chaos? Fertil Steril 2000;73:1261-1262.
3. Franks S: Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 1989;31:87-120.
4. Yen SS: The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980;12:177-207.
5. Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-1174.
6. Dunaif A, Finegood DT: β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:942-947.
7. Mather KJ, Kwan F, Corenblum B: Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 2000;73:150-156.
8. Park KH, Kim JY, Ahn CW, Song YD, Lim SK, Lee HC: Polycystic ovarian syndrome (PCOS) and insulin resistance. Int J Gynaecol Obstet 2001;74:261-267.
9. Grulet H, Hecart AC, Delemer B, Gross A, Sulmont V, Leutenegger M, Caron J: Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf) 1993;38:621-626.
10. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SS: Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854-2864.
11. Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, Mauri M, Alfayate R: Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 1999;72:32-40.
12. Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS: Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 2000;15:1266-1274.
13. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ: Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin-dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-1998.
14. Behrman HR, Kodaman PH, Preston SL, Gao S: Oxidative stress and the ovary. J Soc Gynecol Investig 2001;8(1 Suppl Proceedings):S40-S42.
15. Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P: Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod 2003;18:2270-2274.
16. Agarwal A, Gupta S, Sharma RK: Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28.
17. García-Pardo L, Granados MD, Gaytán F, Padilla CA, Martínez-Galisteo E, Morales C, Sánchez-Criado JE, Barcéna JA: Immunolocalization of glutaredoxin in the human corpus luteum. Mol Hum Reprod 1999;5:914-919.
18. Suzuki T, Sugino N, Fukaya T, Sugiyama S, Uda T, Takaya R, Yajima A, Sasano H: Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril 1999;72:720-726.
19. Agarwal A, Allamaneni SS: Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online 2004;9:338-347.
20. Sasaki J, Sato EF, Nomura T, Mori H, Watanabe S, Kanda S, Watanabe H, Utsumi K, Inoue M: Detection of manganese superoxide dismutase mRNA in the theca interna cells of rat ovary during the ovulatory process by in situ hybridization. Histochemistry 1994;102:173-176.
21. Tarin JJ, Brines J, Cano A: Antioxidants may protect against infertility. Hum Reprod 1998;13:1415-1416.
22. Menon V, Ram M, Dorn J, Armstrong D, Muti P, Freudenheim JL, Browne R, Schunemann H, Trevisan M: Oxidative stress and glucose levels in a population-based sample. Diabet Med 2004;21:1346-1352.
23. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F: Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabète Métab 1992;18:264-271.
24. Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, Maru Y: Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species dependent pathway. J Biol Chem 2004;279:4075-4083.
25. Sabuncu T, Vural H, Harma M, Harma M: Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001;34:407-413.
26. Fenkci V, Fenkci S, Yilmazer M, Serteser M: Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123-127.
27. Dincer Y, Akcay T, Erdem T, Saygili EI, Gundogdu S: DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome. Scand J Clin Lab Invest 2005;65:721-728.
28. González F, Rote NS, Minium J, Kirwan JP: Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:336-340.
29. Palacio JR, Iborra A, Ulcova-Gallova Z, Badia R, Martínez P: The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol 2006;144:217-222.
30. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
31. van Wely M, Bayram N, van der Veen F, Bossuyt PM: Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome. Hum Reprod 2005;20:1827-1832.
32. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
33. Dumesic DA, Abbott DH, Eisner JR, Herrmann RR, Reed JE, Welch TJ, Jensen MD: Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. Fertil Steril 1998;70:94-101.
34. Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE: Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 2004;82:893-902.
35. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
36. Legro RS, Finegood D, Dunaif A: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-2698.
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
38. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ: Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002;77:209-215.
39. Yildirim B, Sabir N, Kaleli B: Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 2003;79:1358-1364.
40. Barbieri RL: Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am J Obstet Gynecol 2000;183:1412-1418.
41. Tiffany TO, Watsky MB, Burtis CA, Thacker LH: Fluorometric fast analyzer: some applications to fluorescence measurements in clinical chemistry. Clin Chem 1973;19:871-882.
42. Comim FV, Spritzer PM: Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome. Fertil Steril 2004;81:108-113.
43. WHO Study Group: Prevention of Diabetes Mellitus. WHO Tech Rep Ser No. 844. Geneva, WHO, 1994.
44. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC: Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998;83:2361-2365.
45. Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, Dewailly D: Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 1995;64:307-312.
46. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-1111.
47. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-285.
48. Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, Elbasan Z: The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Can J Cardiol 2005;21:851-855.
49. Yilmaz M, Bukan N, Ayvaz G, Karakoc A, Toruner F, Cakir N, Arslan M: The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod 2005;20:3333-3340.
50. Baillargeon JP, Nestler JE: Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 2006;91:22-24.
51. Jonard S, Dewailly D: The follicular excess in polycystic ovaries, due to intraovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10:107-117.
52. Cataldo NA, Dumesic DA, Goldsmith PC, Jaffe RB: Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis. Hum Reprod 2000;15:1889-1897.
53. Tsai-Turton M, Luderer U: Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles. Endocrinology 2006;147:1224-1236.
54. Eppig JJ, Hosoe M, O'Brien MJ, Pendola FM, Requena A, Watanabe S: Conditions that affect acquisition of developmental competence by mouse oocytes in vitro: FSH, insulin, glucose and ascorbic acid. Mol Cell Endocrinol 2000;163:109-116.
55. Murray AA, Molinek MD, Baker SJ, Kojima FN, Smith MF, Hillier SG, Spears N: Role of ascorbic acid in promoting follicle integrity and survival in intact mouse ovarian follicles in vitro. Reproduction 2001;121:89-96.
56. Thomas FH, Leask R, Srsen V, Riley SC, Spears N, Telfer EE: Effect of ascorbic acid on health and morphology of bovine preantral follicles during long-term culture. Reproduction 2001;122:487-495.
57. Otala M, ErkkiläK, Tuuri T, Sjöberg J, Suomalainen L, Suikkari AM, Pentikainen V, Dunkel L: Cell death and its suppression in human ovarian tissue culture. Mol Hum Reprod 2002;8:228-236.
58. Behrman HR, Preston SL, Aten RF, Rinaudo P, Zreik TG: Hormone induction of ascorbic acid transport in immature granulosa cells. Endocrinology 1996;137:4316-4321.
59. Hanukoglu I: Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 2006;38:171-196.
60. Miller JK, Brzezinska-Slebodzinska E, Madsen FC: Oxidative stress, antioxidants, and animal function. J Dairy Sci 1993;76:2812-2823.
61. Thorlacius-Ussing O, Danscher G: Selenium in the anterior pituitary of rats exposed to sodium selenite: light and electron microscopic localization. Toxicol Appl Pharmacol 1985;81:67-74.
62. Karanth S, Yu WH, Walczewska A, Mastronardi CA, McCann SM: Ascorbic acid stimulates gonadotropin release by autocrine action by means of NO. Proc Natl Acad Sci USA 2001;98:11783-11788.
63. Karanth S, Yu WH, Mastronardi CA, McCann SM: Vitamin E stimulates luteinizing hormone-releasing hormone and ascorbic acid release from medial basal hypothalami of adult male rats. Exp Biol Med (Maywood) 2003;228:779-785.